- TWD1.57bn
- TWD4.56bn
- TWD2.57bn
- 12
- 44
- 30
- 14
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,046 | 3,267 | 3,699 | 3,068 | 2,570 |
Cost of Revenue | |||||
Gross Profit | 525 | 666 | 805 | 426 | -136 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,505 | 2,951 | 3,299 | 3,181 | 3,118 |
Operating Profit | 541 | 317 | 401 | -113 | -548 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 565 | 396 | 500 | -182 | -564 |
Provision for Income Taxes | |||||
Net Income After Taxes | 546 | 346 | 387 | -163 | -462 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 545 | 345 | 365 | -147 | -427 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 545 | 345 | 365 | -147 | -427 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.92 | 2.95 | 2.89 | -1.29 | -3.75 |
Dividends per Share | |||||
Special Dividends per Share |